Trialect

Active

Career Development Award (CDA)

American Society of Clinical Oncology

The Career Development Award (CDA) provides research funding to clinical investigators, who have received their initial faculty appointment, as they work to establish an independent clinical cancer research program. This is a mentored award and the research project is conducted under the guidance of an experienced mentor in the proposed research area. The research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Proposals with a predominant focus on in vitro or animal studies (even if clinically relevant) are not allowed. Applications in all areas of cancer research are accepted from U.S. and international applicants.

Specialties

Cancer

Drug Development

Radiation Oncology

Clinical Trials

Oncology

Eligibility Requirements

Applicants must meet the following criteria to qualify for a CDA:

Be a physician (MD, DO or international equivalent) working in any country.
Be in the first to fourth year of a full-time primary faculty appointment in a clinical department at an academic medical institution at the time of grant submission. Application must be submitted before the applicant has had four full years as faculty. Faculty appointment may begin with the entry-level faculty position within the applicant’s institution (i.e., Instructor/Lecturer, Assistant Professor, Assistant Member).
Have a valid, active medical license in the country where the research will be conducted at the time of application.
Have completed productive postdoctoral research and demonstrated the ability to undertake independent investigator-initiated clinical research.
Be an ASCO member or have submitted a membership application with the grant application. To apply for new membership, or to renew an existing membership, go to asco.org/membership.
Be able to commit at least 50% of full-time effort in research (applies to total research, not just the proposed project) during the award period.
Have a mentor from the sponsoring institution who must provide a letter of support. If the mentor is not an ASCO Member, a supporting letter from an ASCO Member from the sponsoring institution must be included.
Be up-to-date and in compliance with all requirements (e.g., progress reports, final reports, budget summaries, IRB approvals, etc.) of any past grants received from Conquer Cancer. Eligible applicants are allowed to hold only one active grant from Conquer Cancer at a time.
Applicants with concurrent federal career development awards (e.g., K23, K08, or any other type of career development award) and institutional training grants (T32, KL2/K12 or equivalent) are eligible to apply provided there are no scientific and budgetary overlaps.
Applicants may not concurrently hold other career development awards from private foundations during the CDA-supported project term. Examples include but are not limited to:
- Alex’s Lemonade Stand Foundation – ‘A’ Award Grant
- American Association for Cancer Research - Career Development Award
- American Cancer Society - Mentored Research Grant
- Damon Runyon Cancer Research Foundation - Clinical Investigator Award
- Doris Duke Charitable Foundation - Clinical Scientist Development Award
- Komen Career Catalyst Award
- Lymphoma Research Foundation - Clinical Investigator Career Development Award
- Leukemia and Lymphoma Society - Career Development Program, Scholar Awards and Scholar in Clinical Research Awards
- Melanoma Research Alliance - Young Investigator Awards
- St. Baldrick’s Foundation – St. Baldrick’s Scholar
Past recipients of training fellowships (e.g., Young Investigator Award or an F32 grant) are eligible to apply.
Applicants should not have been a Principal Investigator on any large project grants (e.g., R01 or international equivalent).

Sponsor Details

Sponsor Institute/Organizations: American Society of Clinical Oncology

Address: 2318 Mill Road, Suite 800 | Alexandria, VA 22314

View Funding Opportunity

Award

Letter Of Intent Deadline:

Oct 17, 2024

Final Deadline:

Oct 17, 2024

Funding Amount:

$200,000

3 awards available. The CDA is a three-year grant totaling $200,000 that supports personnel and/or research expenses, and travel to attend the Conquer Cancer Grants and Awards Ceremony at the ASCO Annual Meeting. The number of CDA grants in each funding cycle is not predetermined by Conquer Cancer. Conquer Cancer is committed to funding the most meritorious applications in all areas of cancer research.